NOTCH1 and cancer: The mechanism by which apatinib, a representative TKI, induces microcirculation damage, hypertension and heart failure through the Notch1 signalling pathway will also be explored at the cellular and animal levels to provide clinical guidance for patients with hypertension induced by cancer treated with TKIs.